Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.

Article English OPEN
Benton, SJ ; McCowan, LM ; Heazell, AEP ; Grynspan, D ; Hutcheon, JA ; Senger, C ; Burke, O ; Chan, Y ; Harding, JE ; Yockell-Lelièvre, J ; Hu, Y ; Chappell, LC ; Griffin, MJ ; Shennan, AH ; Magee, LA ; Gruslin, A ; von Dadelszen, P (2016)
  • Publisher: Elsevier
  • Journal: volume 42, pages 1-8 (issn: 0143-4004)
  • Related identifiers: doi: 10.1016/j.placenta.2016.03.010
  • Subject: Developmental Biology | Obstetrics and Gynaecology | Reproductive Medicine

Introduction: Discriminating between placentally-mediated fetal growth restriction and constitutionally-small fetuses is a challenge in obstetric practice. Placental growth factor (PlGF), measurable in the maternal circulation, may have this discriminatory capacity. Methods: Plasma PlGF was measured in women presenting with suspected fetal growth restriction (FGR; ultrasound fetal abdominal circumference <10th percentile for gestational age) at sites in Canada, New Zealand and the United Kingdom. When available, placenta tissue underwent histopathological examination for lesions indicating placental dysfunction, blinded to PlGF and clinical outcome. Lesions were evaluated according to pre-specified severity criteria and an overall severity grade was assigned (0–3, absent to severe). Low PlGF (concentration <5th percentile for gestational age) to identify placental FGR (severity grade ≥2) was assessed and compared with routine parameters for fetal assessment. For all cases, the relationship between PlGF and the sampling-to-delivery interval was determined. Results: Low PlGF identified placental FGR with an area under the receiver-operator characteristic curve of 0.96 [95% CI 0.93–0.98], 98.2% [95% CI 90.5–99.9] sensitivity and 75.1% [95% CI 67.6–81.7] specificity. Negative and positive predictive values were 99.2% [95% CI 95.4–99.9] and 58.5% [95% CI 47.9–68.6], respectively. Low PlGF outperformed gestational age, abdominal circumference and umbilical artery resistance index in predicting placental FGR. Very low PlGF (<12 pg/mL) was associated with shorter sampling-to-delivery intervals than normal PlGF (13 vs. 29.5 days, P<0.0001). Discussion: Low PlGF identifies small fetuses with significant underlying placental pathology and is a promising tool for antenatal discrimination of FGR from fetuses who are constitutionally-small.
  • References (39)
    39 references, page 1 of 4

    [1] A.C.G. Breeze, C.C. Lees, Prediction and perinatal outcomes of fetal growth restriction, Semin. Fet Neonat. Med. 12 (5) (2007) 383e397.

    [2] T.J. Garite, R. Clark, J.A. Thorp, Intrauterine growth restriction increases morbidity and mortality among premature neonates, Am J Obstet Gynecol. 191 (2) (2004) 481e487.

    [3] H.L. Halliday, Neonatal management and long-term sequelae, Best. Prac. Res. Clin. Obstet. 23 (6) (2009) 871e880.

    [4] Royal College of Obstetricians and Gynaecologists UK, Green-top Guideline No. 31: the Investigation and Management of the Small-for Gestational-age Fetus, 2013. www.rcog.org.uk/clinical-guidance.

    [5] F. Figueras, E. Gratacos, Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol, Fetal Diagn. Ther. 36 (2) (2014) 86e98.

    [6] American College of Obstetricians and Gynecologists (ACOG), Practice bulletin number 134: fetal growth restriction, Obstet. Gynecol. 121 (2013) 1122e1133.

    [7] J. Zhang, M. Merialdi, L.D. Platt, M.S. Kramer, Defining normal and abnormal fetal growth: promises and challenges, Am. J. Obstet. Gynecol. 202 (6) (2010) 522e528.

    [8] P.W. Soothill, C.S. Bobrow, R. Holmes, Small for gestational age is not diagnosis, Ultrasound Obstet. Gynecol. 13 (1999) 225e228.

    [9] S.J. Benton, Y. Hu, X. Fang, et al., Can placental growth factor identify placental intrauterine growth restriction in small for gestational age fetuses? Am. J. Obstet. Gynecol. 206 (2) (2012) 163 e1-7.

    [10] L.A. Magee, A. Pels, M. Helewa, E. Rey, P. von Dadelszen, SOGC clinical practice guideline: diagnosis, evaluation, and management of the hypertensive disorders of pregnancy, J. Obstet. Gynaecol. Can. 36 (5) (2014) 416e438.

  • Related Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark